Edgewell Personal Care Company (EPC) reported $2.24B of revenue for the twelve months ended Jun 30, 2026. That is up 11.6% from the year before. Revenue for fiscal 2025 was $2.22B.

No. Edgewell Personal Care Company reported a net loss of $93.20M for the twelve months ended Jun 30, 2026.

How much cash and debt does EPC have?

Edgewell Personal Care Company reported $397.10M in cash and cash equivalents and $1.25B of debt on its most recent balance sheet in SEC filings.

How fast is EPC revenue growing?

Edgewell Personal Care Company's revenue changed -1.3% in fiscal 2025, to $2.22B. Its compound annual growth rate was +2.7% over 5 years.

What is EPC gross margin?

Edgewell Personal Care Company's gross profit was $885.90M on $2.24B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 39.5%.

What is EPC free cash flow?

Edgewell Personal Care Company generated $52.40M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $121.20M less capital expenditures.

What is EPC earnings per share?

Diluted earnings per share were -$1.99 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.

When did EPC last report financial results?

The latest statements here come from Edgewell Personal Care Company's 10-Q filed on Aug 5, 2026, covering the period ended Jun 30, 2026.

Financials · EPC

Edgewell Personal Care Company (EPC) financials

For the twelve months ended Jun 30, 2026, Edgewell Personal Care Company reported $2.24B of revenue and -$93.20M of net income.

Revenue, TTM: $2.24B
Revenue growth, YoY: +11.6%
Net income, TTM: -$93.20M
Net margin: -4.2%
Free cash flow, TTM: $52.40M
EPS, diluted, TTM: -$1.99
Cash: $397.10M
Total debt: $1.25B
P/S: 0.61
Market cap: $1.36B

Annual revenue$2.22B

FY2017FY2025

Annual net income$25.40M

FY2016FY2025

Annual free cash flow$41.40M

FY2016FY2025

EPC revenue and earnings growth

EPC revenueQ3 2026$570.10M

Quarter YoY: +1.7%
QoQ: +9.7%
FY YoY: -1.3%
5Y CAGR: +2.7%

EPC revenue was $570.10M in fiscal Q3 2026 (ended Jun 30, 2026), up 1.7% from a year earlier and up 9.7% from the prior quarter. For the full fiscal 2025 it was $2.22B, down 1.3% from fiscal 2024. Compound annual growth was +2.7% over 5 years. It rose in 4 of the last 8 fiscal years.

EPC net incomeQ3 2026$13.70M

Quarter YoY: -52.9%
FY YoY: -74.2%
5Y CAGR: -17.8%

EPC net income was $13.70M in fiscal Q3 2026 (ended Jun 30, 2026), down 52.9% from a year earlier. For the full fiscal 2025 it was $25.40M, down 74.2% from fiscal 2024. Compound annual growth was -17.8% over 5 years. It rose in 2 of the last 5 fiscal years.

EPC EPSQ3 2026$0.29

Quarter YoY: -53.2%
FY YoY: -73.1%
5Y CAGR: -15.6%

EPC diluted EPS was $0.29 in fiscal Q3 2026 (ended Jun 30, 2026), down 53.2% from a year earlier. For the full fiscal 2025 it was $0.53, down 73.1% from fiscal 2024. Compound annual growth was -15.6% over 5 years.

EPC free cash flowQ3 2026$103.10M

Quarter YoY: +3.8%
QoQ: +155.8%
5Y CAGR: -25.9%
10Y CAGR: -1.8%

EPC free cash flow was $103.10M in fiscal Q3 2026 (ended Jun 30, 2026), up 3.8% from a year earlier and up 155.8% from the prior quarter. For the full fiscal 2025 it was $41.40M, compared with -$287.50M in fiscal 2024. Compound annual growth was -25.9% over 5 years and -1.8% over 10 years.

Export CSV

Income statement

Income statement
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue	$2.22B	$2.25B	$2.25B	$2.17B	$2.09B	$1.95B	$2.14B	$2.23B	$2.30B	-
Cost of revenue	$1.30B	$1.30B	$1.31B	$1.29B	$1.14B	$1.07B	$1.17B	$1.20B	$1.17B	$1.20B
Gross profit	$924.90M	$955.70M	$940.80M	$880.50M	$951.20M	$880.90M	$966.60M	$1.03B	$1.13B	$1.16B
Research and development	$57.60M	$58.40M	$58.50M	$55.50M	$57.80M	$55.30M	$53.50M	$61.10M	$67.60M	$71.90M
Selling, general and admin	$425.00M	$430.10M	$409.60M	-	-	-	-	-	-	-
Operating income	$96.60M	$199.30M	$227.00M	$182.30M	$239.90M	$176.00M	$243.80M	-	-	-
Interest expense	$73.20M	$76.50M	$78.50M	$71.40M	$67.90M	$61.20M	$62.60M	$68.00M	$69.20M	$71.80M
Pre-tax income	$23.60M	$120.90M	$147.70M	$124.10M	$147.10M	$87.30M	-$390.30M	$163.80M	-$52.90M	$219.90M
Income tax	-$1.80M	$22.30M	$33.00M	$24.60M	$29.30M	$19.70M	-$18.10M	$60.50M	-$58.60M	$41.20M
Net income	$25.40M	$98.60M	$114.70M	$99.50M	$117.80M	$67.60M	-$372.20M	$103.30M	$5.70M	$178.70M
EPS, basic	$0.53	$1.98	$2.24	$1.87	$2.17	$1.25	-$6.88	$1.90	$0.10	$3.02
EPS, diluted	$0.53	$1.97	$2.21	$1.85	$2.13	$1.24	-$6.88	$1.90	$0.10	$2.99
Diluted shares	47.6M	50.1M	51.8M	53.6M	55.2M	54.6M	54.1M	54.5M	57.5M	59.7M

Balance sheet

Balance sheet
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Cash and equivalents	$225.70M	$209.10M	$216.40M	$188.70M	$479.20M	$364.70M	$341.60M	$266.40M	$502.90M	$738.90M
Receivables	$137.80M	$109.40M	$106.20M	$136.90M	$150.70M	$158.80M	$205.60M	$226.50M	$224.10M	$260.70M
Inventory	$433.80M	$477.30M	$492.40M	$449.30M	$345.70M	$314.10M	$357.20M	$329.50M	$333.50M	$309.20M
Current assets	$995.50M	$936.00M	$962.40M	$942.20M	$1.14B	$983.60M	$1.04B	$951.20M	$1.19B	$1.45B
Goodwill	$1.14B	$1.34B	$1.33B	$1.32B	$1.16B	$1.16B	$1.03B	$1.45B	$1.45B	$1.42B
Total assets	$3.76B	$3.73B	$3.74B	$3.71B	$3.67B	$3.54B	$3.42B	$3.95B	$4.19B	$4.77B
Current liabilities	$565.50M	$563.60M	$523.40M	$539.50M	$536.80M	$510.50M	$659.60M	$717.00M	$524.40M	$868.20M
Short-term debt	-	-	-	$0	$0	$0	$117.00M	$184.90M	$0	$281.80M
Long-term debt	$1.38B	$1.27B	$1.36B	$1.39B	$1.23B	$1.24B	$1.10B	$1.10B	$1.53B	$1.54B
Total debt	$1.38B	$1.27B	$1.36B	$1.39B	$1.23B	$1.24B	$1.21B	$1.29B	$1.53B	$1.83B
Total liabilities	$2.20B	$2.15B	$2.20B	$2.25B	$2.09B	$2.11B	$2.12B	$2.21B	$2.45B	$2.94B
Shareholders' equity	$1.55B	$1.58B	$1.54B	$1.47B	$1.59B	$1.44B	$1.30B	$1.74B	$1.74B	$1.83B

Cash flow

Cash flow
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Operating cash flow	$118.40M	-$231.00M	-$216.10M	$102.00M	$229.00M	$232.60M	$190.60M	$259.40M	$313.60M	$186.80M
Capital expenditures	$77.00M	$56.50M	$49.50M	$56.40M	$56.80M	$47.70M	$58.00M	$62.00M	$69.00M	$69.50M
Free cash flow	$41.40M	-$287.50M	-$265.60M	$45.60M	$172.20M	$184.90M	$132.60M	$197.40M	$244.60M	$117.30M
Investing cash flow	-$72.90M	-$62.40M	-$50.50M	-$355.40M	-$48.70M	-$196.40M	-$45.50M	-$118.80M	-$84.60M	-$69.50M
Financing cash flow	-$30.00M	-$179.40M	-$146.50M	-$17.60M	-$65.40M	-$18.70M	-$63.80M	-$379.60M	-$478.00M	-$93.40M
Dividends paid	$29.30M	$30.70M	$31.50M	$32.60M	$25.60M	$0	$0	-	$0	$0
Share repurchases	$90.20M	$58.50M	$75.20M	$125.30M	$9.20M	$0	$0	$124.40M	$165.40M	$196.60M
Stock-based compensation	$24.50M	$26.50M	$27.50M	$23.80M	$27.30M	$19.20M	$17.80M	$17.00M	$22.20M	$25.60M
Depreciation and amortization	$88.80M	$88.00M	$91.40M	$89.90M	$87.10M	$88.80M	$93.80M	$97.60M	$94.40M	$92.60M

Key ratios

Key ratios
Line item	FY2025 Sep 30, 2025	FY2024 Sep 30, 2024	FY2023 Sep 30, 2023	FY2022 Sep 30, 2022	FY2021 Sep 30, 2021	FY2020 Sep 30, 2020	FY2019 Sep 30, 2019	FY2018 Sep 30, 2018	FY2017 Sep 30, 2017	FY2016 Sep 30, 2016
Revenue growth, YoY	-1.3%	0.1%	3.7%	4.0%	7.1%	-8.9%	-4.2%	-2.8%	-	-
Net income growth, YoY	-74.2%	-14.0%	15.3%	-15.5%	74.3%	-	-	1712.3%	-96.8%	-
EPS growth, YoY	-73.1%	-10.9%	19.5%	-13.1%	71.8%	-	-	1800.0%	-96.7%	-
Gross margin	41.6%	42.4%	41.8%	40.5%	45.6%	45.2%	45.1%	46.2%	49.0%	-
Operating margin	4.3%	8.8%	10.1%	8.4%	11.5%	9.0%	11.4%	-	-	-
Net margin	1.1%	4.4%	5.1%	4.6%	5.6%	3.5%	-17.4%	4.6%	0.2%	-
Free cash flow margin	1.9%	-12.8%	-11.8%	2.1%	8.2%	9.5%	6.2%	8.8%	10.6%	-
Return on equity	1.6%	6.2%	7.4%	6.8%	7.4%	4.7%	-28.6%	5.9%	0.3%	9.8%
Return on assets	0.7%	2.6%	3.1%	2.7%	3.2%	1.9%	-10.9%	2.6%	0.1%	3.7%
Current ratio	1.76	1.66	1.84	1.75	2.12	1.93	1.58	1.33	2.26	1.67
Debt to equity	0.89	0.80	0.88	0.95	0.78	0.86	0.93	0.74	0.88	1.00

Income statement

Income statement
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Revenue	$570.10M	$519.50M	$422.80M	$731.40M	$560.40M	$516.60M	$415.10M	$517.60M	$647.80M	$599.40M	$488.90M	$534.10M
Cost of revenue	$327.60M	$302.60M	$261.80M	$465.90M	$310.30M	$279.70M	$242.60M	$304.80M	$360.70M	$341.30M	$291.20M	$305.50M
Gross profit	$242.50M	$216.90M	$161.00M	$265.50M	$250.10M	$236.90M	$172.50M	$212.80M	$287.10M	$258.10M	$197.70M	$228.60M
Research and development	$13.30M	$14.90M	$13.80M	$17.40M	$13.50M	$13.40M	$13.40M	$16.30M	$14.60M	$14.20M	$13.30M	$15.90M
Selling, general and admin	$108.30M	$111.00M	$102.40M	$121.90M	$100.70M	$102.80M	$99.60M	$109.20M	$110.10M	$107.50M	$103.30M	$112.40M
Operating income	$25.00M	$18.40M	-$18.90M	-$6.60M	$45.00M	$49.00M	$9.30M	$20.40M	$82.70M	$70.10M	$26.10M	$52.10M
Interest expense	$16.70M	$17.90M	$19.30M	$14.80M	$19.40M	$20.20M	$18.80M	$17.50M	$18.80M	$20.40M	$19.80M	$18.70M
Pre-tax income	$18.00M	$7.90M	-$36.90M	-$23.50M	$28.50M	$31.40M	-$12.70M	$5.40M	$62.50M	$47.00M	$6.00M	$33.30M
Income tax	$5.70M	$3.90M	-$7.70M	-$16.80M	$7.00M	$10.60M	-$2.60M	-$3.40M	$13.50M	$11.00M	$1.20M	$3.40M
Net income	$13.70M	-$10.60M	-$65.70M	-$30.60M	$29.10M	$29.00M	-$2.10M	$8.80M	$49.00M	$36.00M	$4.80M	$29.90M
EPS, basic	$0.30	-$0.23	-$1.41	-$0.65	$0.62	$0.60	-$0.04	$0.17	$0.99	$0.72	$0.10	$0.59
EPS, diluted	$0.29	-$0.22	-$1.41	-$0.65	$0.62	$0.60	-$0.04	$0.18	$0.98	$0.72	$0.09	$0.58
Diluted shares	46.6M	46.8M	46.6M	-	47.0M	48.2M	48.7M	-	50.1M	50.2M	50.5M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Cash and equivalents	$397.10M	$299.70M	$223.30M	$225.70M	$199.60M	$170.10M	$175.50M	$209.10M	$196.10M	$196.20M	$214.20M	$216.40M
Receivables	$119.40M	$185.40M	$154.00M	$137.80M	$153.20M	$178.20M	$120.50M	$109.40M	$155.00M	$130.60M	$112.50M	$106.20M
Inventory	$433.00M	$450.10M	$461.20M	$433.80M	$488.40M	$512.20M	$501.60M	$477.30M	$455.90M	$496.40M	$521.90M	$492.40M
Current assets	$1.11B	$1.11B	$1.06B	$995.50M	$1.00B	$1.01B	$945.20M	$936.00M	$958.70M	$994.80M	$1.01B	$962.40M
Goodwill	$1.13B	$1.13B	$1.14B	$1.14B	$1.34B	$1.33B	$1.33B	$1.34B	$1.33B	$1.33B	$1.34B	$1.33B
Total assets	$3.54B	$3.53B	$3.77B	$3.76B	$3.79B	$3.77B	$3.70B	$3.73B	$3.71B	$3.76B	$3.79B	$3.74B
Current liabilities	$603.60M	$613.80M	$497.50M	$565.50M	$567.40M	$536.30M	$459.00M	$563.60M	$535.10M	$541.90M	$467.70M	$523.40M
Long-term debt	$1.25B	$1.24B	$1.52B	$1.38B	$1.37B	$1.43B	$1.44B	$1.27B	$1.29B	$1.35B	$1.45B	$1.36B
Total debt	$1.25B	$1.24B	$1.52B	$1.38B	$1.37B	$1.43B	$1.44B	$1.27B	$1.29B	$1.35B	$1.45B	$1.36B
Total liabilities	$2.08B	$2.09B	$2.28B	$2.20B	$2.23B	$2.26B	$2.20B	$2.15B	$2.13B	$2.21B	$2.24B	$2.20B
Shareholders' equity	$1.46B	$1.45B	$1.49B	$1.55B	$1.57B	$1.51B	$1.50B	$1.58B	$1.58B	$1.55B	$1.55B	$1.54B

Cash flow

Cash flow
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Operating cash flow	$118.70M	$54.30M	-$125.90M	$74.10M	$114.80M	$45.10M	-$115.60M	-$388.30M	$101.20M	$129.00M	-$72.90M	-$384.40M
Capital expenditures	$15.60M	$14.00M	$11.60M	$27.60M	$15.50M	$17.10M	$16.80M	$25.90M	$12.60M	$11.50M	$6.50M	$18.40M
Free cash flow	$103.10M	$40.30M	-$137.50M	$46.50M	$99.30M	$28.00M	-$132.40M	-$414.20M	$88.60M	$117.50M	-$79.40M	-$402.80M
Investing cash flow	-$14.10M	$325.00M	-$9.90M	-$27.60M	-$12.30M	-$17.30M	-$15.70M	-$25.50M	-$17.20M	-$13.70M	-$6.00M	-$18.90M
Financing cash flow	-$7.30M	-$300.80M	$133.40M	-$19.10M	-$83.40M	-$37.40M	$109.90M	-$40.10M	-$79.90M	-$129.20M	$69.80M	-$14.20M
Dividends paid	$7.00M	$7.10M	$7.40M	$6.90M	$7.20M	$7.30M	$7.90M	$7.40M	$7.50M	$8.20M	$7.60M	$7.70M
Share repurchases	$0	$15.80M	$0	$0	$24.50M	$35.40M	$30.30M	$18.30M	$9.90M	$15.30M	$15.00M	$30.00M
Stock-based compensation	$5.70M	$5.60M	$3.40M	$5.70M	$6.40M	$6.30M	$6.10M	$6.10M	$7.10M	$6.30M	$7.00M	$7.70M
Depreciation and amortization	$18.60M	$19.10M	$21.30M	$23.20M	$22.10M	$21.80M	$21.70M	$21.40M	$21.70M	$22.40M	$22.50M	$23.30M

Key ratios

Key ratios
Line item	Q3 2026 Jun 30, 2026	Q2 2026 Mar 31, 2026	Q1 2026 Dec 31, 2025	Q4 2025* Sep 30, 2025	Q3 2025 Jun 30, 2025	Q2 2025 Mar 31, 2025	Q1 2025 Dec 31, 2024	Q4 2024* Sep 30, 2024	Q3 2024 Jun 30, 2024	Q2 2024 Mar 31, 2024	Q1 2024 Dec 31, 2023	Q4 2023 Sep 30, 2023
Revenue growth, YoY	1.7%	0.6%	1.9%	41.3%	-13.5%	-13.8%	-15.1%	-3.1%	-0.3%	0.2%	4.2%	-0.5%
Net income growth, YoY	-52.9%	-	-	-	-40.6%	-19.4%	-	-70.6%	-7.5%	85.6%	-61.3%	-11.3%
EPS growth, YoY	-53.2%	-	-	-	-36.7%	-16.7%	-	-69.0%	-3.9%	94.6%	-62.5%	-9.4%
Gross margin	42.5%	41.8%	38.1%	36.3%	44.6%	45.9%	41.6%	41.1%	44.3%	43.1%	40.4%	42.8%
Operating margin	4.4%	3.5%	-4.5%	-0.9%	8.0%	9.5%	2.2%	3.9%	12.8%	11.7%	5.3%	9.8%
Net margin	2.4%	-2.0%	-15.5%	-4.2%	5.2%	5.6%	-0.5%	1.7%	7.6%	6.0%	1.0%	5.6%
Free cash flow margin	18.1%	7.8%	-32.5%	6.4%	17.7%	5.4%	-31.9%	-80.0%	13.7%	19.6%	-16.2%	-75.4%
Current ratio	1.84	1.81	2.12	1.76	1.77	1.89	2.06	1.66	1.79	1.84	2.15	1.84
Debt to equity	0.85	0.86	1.02	0.89	0.88	0.95	0.96	0.80	0.82	0.87	0.94	0.88

Source: XBRL data Edgewell Personal Care Company files with the SEC, latest filing dated Aug 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

EPC peers

Company	Revenue	Growth	Net income	Net margin	Market cap
EPC	$2.24B	+11.6%	-$93.20M	-4.2%	$1.36B
PGProcter & Gamble Company	$87.92B	+3.5%	$16.03B	18.2%	$390.13B
ULUnilever PLC	€50.50B	-3.8%	€9.47B	18.7%	$143.50B
ECLEcolab Inc.	$17.37B	+9.3%	$2.08B	12.0%	$86.03B
CLColgate-Palmolive Company	$21.28B	+5.9%	$2.05B	9.6%	$77.85B
ELEstee Lauder Companies Inc.	$15.28B	+5.8%	$368.00M	2.4%	$41.00B
HLNHaleon plc	£11.03B	-1.8%	£1.67B	15.1%	$39.43B
KVUEKenvue Inc.	$15.53B	+3.5%	$1.69B	10.9%	$37.57B
CHDChurch & Dwight Company Inc.	$6.25B	+1.7%	$774.80M	12.4%	$26.27B

EPC FAQ

9 questions

What is EPC revenue?
Edgewell Personal Care Company (EPC) reported $2.24B of revenue for the twelve months ended Jun 30, 2026. That is up 11.6% from the year before. Revenue for fiscal 2025 was $2.22B.
Is EPC profitable?
No. Edgewell Personal Care Company reported a net loss of $93.20M for the twelve months ended Jun 30, 2026.
How much cash and debt does EPC have?
Edgewell Personal Care Company reported $397.10M in cash and cash equivalents and $1.25B of debt on its most recent balance sheet in SEC filings.
How fast is EPC revenue growing?
Edgewell Personal Care Company's revenue changed -1.3% in fiscal 2025, to $2.22B. Its compound annual growth rate was +2.7% over 5 years.
What is EPC gross margin?
Edgewell Personal Care Company's gross profit was $885.90M on $2.24B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 39.5%.
What is EPC free cash flow?
Edgewell Personal Care Company generated $52.40M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $121.20M less capital expenditures.
What is EPC earnings per share?
Diluted earnings per share were -$1.99 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
When did EPC last report financial results?
The latest statements here come from Edgewell Personal Care Company's 10-Q filed on Aug 5, 2026, covering the period ended Jun 30, 2026.
Where does this EPC financial data come from?
Quantisnow builds these statements from the structured XBRL data Edgewell Personal Care Company files with the SEC. It is provided for information only and is not investment advice.